Ferlay J EM, Lam F, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today Lyon, France International Agency for Research on Cancer; 2018 [Available from: https://gco.iarc.fr/today.
Google Scholar
ECIS - European Cancer Information System From https://ecis.jrc.ec.europa.eu, accessed on 19/08/2019. © European Union, 2019.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-717.
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3983–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001;344(11):783–92.
Article
CAS
PubMed
Google Scholar
van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999–2009.
Article
PubMed
Google Scholar
Van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530–6.
Article
Google Scholar
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784–92.
Article
CAS
PubMed
Google Scholar
Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A. Contribution of Breast Cancer to Overall Mortality for US Women. Med Decis Making. 2018;38(1_suppl):24s–31s.
Article
PubMed
PubMed Central
Google Scholar
Kalager M, Zelen M, Langmark F, Adami HO. Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med. 2010;363(13):1203–10.
Article
CAS
PubMed
Google Scholar
Clinical Practice Guidelines We Can Trust. Washington DC: National Academy Press (US); 2011. Available from: https://www.ncbi.nlm.nih.gov/books/NBK209546/.
Google Scholar
Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.
Article
PubMed
PubMed Central
Google Scholar
Davis DA, Taylor-Vaisey A. Translating guidelines into practice: a systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. Can Med Assoc J. 1997;157(4):408–16.
Ford I, Norrie J. Pragmatic trials. N Engl J Med. 2016;375(5):454–63.
Article
PubMed
Google Scholar
Gandhi S, Verma S, Ethier JL, Simmons C, Burnett H, Alibhai SM. A systematic review and quality appraisal of international guidelines for early breast cancer systemic therapy: Are recommendations sensitive to different global resources? Breast (Edinburgh, Scotland). 2015;24(4):309–17.
Article
CAS
Google Scholar
Arts DL, Voncken AG, Medlock S, Abu-Hanna A, van Weert HC. Reasons for intentional guideline non-adherence: a systematic review. Int J Med Inform. 2016;89:55–62.
Article
PubMed
Google Scholar
Andreano A, Rebora P, Valsecchi MG, Russo AG. Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach. Breast Cancer Res Treat. 2017;164(1):119–31.
Article
PubMed
Google Scholar
Ebner F, Hancke K, Blettner M, Schwentner L, Wockel A, Kreienberg R, et al. Aggressive intrinsic subtypes in breast Cancer: a predictor of guideline adherence in older patients with breast Cancer? Clin Breast Cancer. 2015;15(4):e189–95.
Article
PubMed
Google Scholar
Ebner F, van Ewijk R, Wockel A, Hancke K, Schwentner L, Fink V, et al. Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients. Breast (Edinburgh, Scotland). 2015;24(3):256–62.
Article
Google Scholar
Wollschlager D, Meng X, Wockel A, Janni W, Kreienberg R, Blettner M, et al. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J. 2018;24(2):120-7.
Jacke CO, Albert US, Kalder M. The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients. BMC Cancer. 2015;15:734.
Article
PubMed
PubMed Central
Google Scholar
Wolters R, Wischhusen J, Stuber T, Weiss CR, Krockberger M, Bartmann C, et al. Guidelines are advantageous, though not essential for improved survival among breast cancer patients. Breast Cancer Res Treat. 2015;152(2):357–66.
Article
PubMed
Google Scholar
Riley RD, Hayden JA, Steyerberg EW, Moons KG, Abrams K, Kyzas PA, et al. Prognosis research strategy (PROGRESS) 2: prognostic factor research. PLoS Med. 2013;10(2):e1001380.
Article
PubMed
PubMed Central
Google Scholar
Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Article
PubMed
PubMed Central
Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.
Article
PubMed
PubMed Central
Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
Article
PubMed
Google Scholar
NIH. Quality Assessment Tool for Before-After (Pre-Post) Studies With No Control Group 2014 [Available from: https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascular-risk-reduction/tools/before-after.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.
Article
CAS
PubMed
Google Scholar
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
Article
PubMed
Google Scholar
Wockel A, Wolters R, Wiegel T, Novopashenny I, Janni W, Kreienberg R, et al. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. Ann Oncol. 2014;25(3):628–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Skoetz N, Goldkuhle M, van Dalen EC, Akl EA, Trivella M, Mustafa RA, et al. GRADE guidelines 27: how to calculate absolute effects for time-to-event outcomes in summary of findings tables and evidence profiles. J Clin Epidemiol. 2020;118:124–31.
Article
PubMed
Google Scholar
Review Manager (RevMan) Version 5.3. ed. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014.
GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2020 (developed by Evidence Prime, Inc.). Available from gradepro.org.
Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, et al. Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients. BMJ. 2015;350:h870.
Article
PubMed
Google Scholar
Moons KGM, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.
Article
PubMed
Google Scholar
de Roos MA, de Bock GH, Baas PC, de Munck L, Wiggers T, de Vries J. Compliance with guidelines is related to better local recurrence-free survival in ductal carcinoma in situ. Br J Cancer. 2005;93(10):1122–7.
Article
PubMed
PubMed Central
Google Scholar
Hancke K, Denkinger MD, Konig J, Kurzeder C, Wockel A, Herr D, et al. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol. 2010;21(4):748–53.
Article
CAS
PubMed
Google Scholar
Mille D, Roy T, Carrere MO, Ray I, Ferdjaoui N, Spath HM, et al. Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center. J Clin Oncol. 2000;18(8):1718–24.
Article
CAS
PubMed
Google Scholar
Poncet B, Colin C, Bachelot T, Jaisson-Hot I, Derain L, Magaud L, et al. Treatment of metastatic breast cancer: a large observational study on adherence to French prescribing guidelines and financial cost of the anti-HER2 antibody trastuzumab. Am J Clin Oncol. 2009;32(4):369–74.
Article
CAS
PubMed
Google Scholar
Sacerdote C, Bordon R, Pitarella S, Mano MP, Baldi I, Casella D, et al. Compliance with clinical practice guidelines for breast cancer treatment: a population-based study of quality-of-care indicators in Italy. BMC Health Serv Res. 2013;13:28.
Article
PubMed
PubMed Central
Google Scholar
Schwentner L, Wockel A, Konig J, Janni W, Ebner F, Blettner M, et al. Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients. BMC Cancer. 2013;13:487.
Article
PubMed
PubMed Central
Google Scholar
Schwentner L, Wolters R, Wischnewsky M, Kreienberg R, Wockel A. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. Breast (Edinburgh, Scotland). 2012;21(2):171–7.
Article
Google Scholar
Schwentner L, Wolters R, Koretz K, Wischnewsky MB, Kreienberg R, Rottscholl R, et al. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-Centre cohort study. Breast Cancer Res Treat. 2012;132(3):1073–80.
Article
CAS
PubMed
Google Scholar
van de Water W, Bastiaannet E, Dekkers OM, de Craen AJ, Westendorp RG, Voogd AC, et al. Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg. 2012;99(6):813–20.
Article
PubMed
Google Scholar
Van Ewijk R, Wockel A, Gundelach T, Hancke K, Janni W, Singer S, et al. Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients. Arch Gynecol Obstet. 2015;291(3):631–40.
Article
PubMed
CAS
Google Scholar
Varga D, Wischnewsky M, Atassi Z, Wolters R, Geyer V, Strunz K, et al. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology. 2010;78(3–4):189–95.
Article
PubMed
Google Scholar
Wockel A, Varga D, Atassi Z, Kurzeder C, Wolters R, Wischnewsky M, et al. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study. Onkologie. 2010;33(1–2):21–8.
PubMed
Google Scholar
Wockel A, Kurzeder C, Geyer V, Novasphenny I, Wolters R, Wischnewsky M, et al. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients. Breast (Edinburgh, Scotland). 2010;19(2):120–7.
Article
Google Scholar
Wimmer T, Ortmann O, Gerken M, Klinkhammer-Schalke M, Koelbl O, Inwald EC. Adherence to guidelines and benefit of adjuvant radiotherapy in patients with invasive breast cancer: results from a large population-based cohort study of a cancer registry. Arch Gynecol Obstet. 2019;299(4):1131-40.
Wollschlager D, Meng X, Wockel A, Janni W, Kreienberg R, Blettner M, et al. Comorbidity-dependent adherence to guidelines and survival in breast cancer-is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients. Breast J. 2018;24(2):120–7.
Article
PubMed
CAS
Google Scholar
Henry NL, Hayes DF, Ramsey SD, Hortobagyi GN, Barlow WE, Gralow JR. Promoting quality and evidence-based care in early-stage breast cancer follow-up. J Natl Cancer Inst. 2014;106(4):dju034.
Article
PubMed
PubMed Central
Google Scholar
Subramanian S, Klosterman M, Amonkar MM, Hunt TL. Adherence with colorectal cancer screening guidelines: a review. Prev Med. 2004;38(5):536–50.
Article
PubMed
Google Scholar
Carpentier MY, Vernon SW, Bartholomew LK, Murphy CC, Bluethmann SM. Receipt of recommended surveillance among colorectal cancer survivors: a systematic review. J Cancer Surviv. 2013;7(3):464–83.
Article
PubMed
PubMed Central
Google Scholar
Ament SM, de Groot JJ, Maessen JM, Dirksen CD, van der Weijden T, Kleijnen J. Sustainability of professionals' adherence to clinical practice guidelines in medical care: a systematic review. BMJ Open. 2015;5(12):e008073.
Article
PubMed
PubMed Central
Google Scholar
Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16.
Article
PubMed
Google Scholar
Ferron G, Martinez A, Gladieff L, Mery E, David I, Delannes M, et al. Adherence to guidelines in gynecologic cancer surgery. Int J Gynecol Cancer. 2014;24(9):1675–8.
Article
PubMed
Google Scholar
Bahtsevani C, Uden G, Willman A. Outcomes of evidence-based clinical practice guidelines: a systematic review. Int J Technol Assess Health Care. 2004;20(4):427–33.
Article
PubMed
Google Scholar
Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet (London, England). 1993;342(8883):1317–22.
Article
CAS
Google Scholar
Lugtenberg M, Burgers JS, Westert GP. Effects of evidence-based clinical practice guidelines on quality of care: a systematic review. Qual Saf Health Care. 2009;18(5):385–92.
Article
CAS
PubMed
Google Scholar
Thomas LH, Cullum NA, McColl E, Rousseau N, Soutter J, Steen N. Guidelines in professions allied to medicine. Cochrane Database Syst Rev. 1999;(1). Art. No.: CD000349. https://doi.org/10.1002/14651858.CD000349.. Available at: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000349/full.
Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 1997;156(12):1705–12.
CAS
PubMed
Google Scholar
Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.
Article
PubMed
Google Scholar
Schünemann HJ, Lerda D, Dimitrova N, Alonso-Coello P, Gräwingholt A, Quinn C, et al. Methods for development of the European Commission initiative on breast Cancer guidelines: recommendations in the era of guideline TransparencyEuropean commission initiative on breast Cancer guidelines. Ann Intern Med. 2019;171(4):273-80.
Haggman-Laitila A, Mattila LR, Melender HL. A systematic review of the outcomes of educational interventions relevant to nurses with simultaneous strategies for guideline implementation. J Clin Nurs. 2017;26(3–4):320–40.
Article
PubMed
Google Scholar
Gagliardi AR, Alhabib S. Trends in guideline implementation: a scoping systematic review. Implement Sci. 2015;10:54.
Article
PubMed
PubMed Central
Google Scholar
Flodgren G, Hall AM, Goulding L, Eccles MP, Grimshaw JM, Leng GC, Shepperd S. Tools developed and disseminated by guideline producers to promote the uptake of their guidelines. Cochrane Database Syst Rev. 2016;(8). Art. No.: CD010669. https://doi.org/10.1002/14651858.CD010669.pub2. Available at: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010669.pub2/full.
Shekelle P, Woolf S, Grimshaw JM, Schunemann HJ, Eccles MP. Developing clinical practice guidelines: reviewing, reporting, and publishing guidelines; updating guidelines; and the emerging issues of enhancing guideline implementability and accounting for comorbid conditions in guideline development. Implement Sci. 2012;7:62.
Article
PubMed
PubMed Central
Google Scholar
Gagliardi AR, Brouwers MC. Do guidelines offer implementation advice to target users? A systematic review of guideline applicability. BMJ Open. 2015;5(2):e007047.
Article
PubMed
PubMed Central
Google Scholar
Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol assess (Winchester, England). 2004;8(6):iii-iv, 1-72.
Davies P, Walker AE, Grimshaw JM. A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implement Sci. 2010;5:14.
Article
PubMed
PubMed Central
Google Scholar
Liang L, Bernhardsson S, Vernooij RW, Armstrong MJ, Bussieres A, Brouwers MC, et al. Use of theory to plan or evaluate guideline implementation among physicians: a scoping review. Implement Sci. 2017;12(1):26.
Article
PubMed
PubMed Central
Google Scholar